Format

Send to

Choose Destination
Acta Cytol. 2019;63(4):257-273. doi: 10.1159/000499509. Epub 2019 May 21.

The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.

Author information

1
Department of Pathology, St Vincent's Hospital, and University of NSW and University of Notre Dame Medical Schools, Sydney, New South Wales, Australia, andrew.field@svha.org.au.
2
South Australian Pathology, Department of Surgical Pathology, Flinders Medical Centre, Flinders University of South Australia, and Clinpath, Adelaide, South Australia, Australia.
3
BreastScreen NSW and Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia.
4
Sydney Breast Clinic, Sydney, New South Wales, Australia.
5
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
6
Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
7
Pathology Department, Beijing Hospital, National Center of Gerontology, Beijing, China.
8
Department of Anatomical Pathology, University of Trieste, Trieste, Italy.
9
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison, Wisconsin, USA.
10
Department of Histopathology, Nottingham University Hospitals, Nottingham, United Kingdom.
11
Connie Johnson Breast Cancer Research Laboratory, Garvan Institute of Medical Research, St Vincent's Hospital, UNSW Medical School, Sydney, New South Wales, Australia.
12
Department of Pathology, University of California San Francisco, San Francisco, California, USA.
13
Department of Anatomical Pathology, University of the Witwatersrand, Johannesburg, South Africa.
14
National Health Laboratory Service, Johannesburg, South Africa.
15
Nippon Koukan Hospital, Kawasaki, Japan.
16
Keio University School of Medicine, Tokyo, Japan.
17
Department of Pathology, Cattinara Hospital, Trieste, Italy.
18
Institute of Clinical Medicine, Department of Pathology, Faculty of Medicine, Akershus University Hospital, University of Oslo, Oslo, Norway.
19
Breast Surgical Oncologist, St Vincent's Private Hospital, Sydney, New South Wales, Australia.
20
Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Sha Tin, Hong Kong.
21
Laboratoire National de Santé, Departement de Pathologie Morphologique et Moleculaire, Dudelange, Luxembourg.
22
Department of Pathology, Sengkang General Hospital, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
23
Institute of Molecular Pathology and Immunology, Instituto de Investigação e Inovação em Saúde and Medical Faculty, University of Porto, Porto, Portugal.

Abstract

The International Academy of Cytology (IAC) gathered together a group of cytopathologists expert in breast cytology who, working with clinicians expert in breast diagnostics and management, have developed the IAC Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy (FNAB) Cytology. The project was initiated with the first cytopathology group meeting in Yokohama at the 2016 International Congress of Cytology. This IAC Yokohama System defines five categories for reporting breast cytology, each with a clear descriptive term for the category, a definition, a risk of malignancy (ROM) and a suggested management algorithm. The key diagnostic cytopathology features of each of the lesions within each category will be presented more fully in a subsequent atlas. The System emphasizes that the crucial requirements for diagnostic breast FNAB cytology are a high standard for the performance of the FNAB and for the making of direct smears, and well-trained experienced cytopathologists to interpret the material. The performance indicators of breast FNAB, including specificity and sensitivity, negative predictive value, positive predictive value and ROM stated in this article have been derived from the recent literature. The current practice of breast FNAB has evolved with the increasing use of ultrasound guidance and rapid on-site evaluation. Two recent publications have shown a range of ROM for the insufficient/inadequate category of 2.6-4.8%, benign 1.4-2.3%, atypical 13-15.7%, suspicious of malignancy 84.6-97.1%, and malignant 99.0-100%. The management algorithm in the System provides options because there are variations in the management of breast lesions using FNAB and core-needle biopsy in those countries utilizing the "triple test" of clinical, imaging, and FNAB assessment, and also variations in the availability of CNB and imaging in low- and middle-income countries. The System will stimulate further discussion and research, particularly in the cytological diagnostic features of specific lesions within each category and in management recommendations. This will lead to continuing improvements in the care of patients with breast lesions and possible modifications to the IAC Yokohama System.

KEYWORDS:

Breast cytology; Fine-needle aspiration biopsy; International Academy of Cytology; Reporting system; Yokohama

PMID:
31112942
DOI:
10.1159/000499509
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center